Skip to main content
logo
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.72
0.00 (0.00%)
Aug 13, 2026, 5:29 PM CET

AlzeCure Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-69.29-47.89-35.96-38.26-56.44-77.93
Depreciation & Amortization
0.951.271.430.480.570.58
Other Adjustments
0.330.240.181.10.20.15
Change in Receivables
0.040.04-0.040-0.01
Changes in Accounts Payable
4.421.47-0-2.16-1.132.01
Changes in Other Operating Activities
12.2710.290.1641.91-43.124.55
Operating Cash Flow
-41.53-34.59-34.233.06-99.91-70.64
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0-0.120--0.05
Other Investing Activities
---0.010-
Investing Cash Flow
-0-0.120.010-0.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
58.5658.5644.550.4294.070
Net Common Stock Issued (Repurchased)
58.5658.5644.550.4294.070
Other Financing Activities
-5.15-5.13-7.810.04-10.32-
Financing Cash Flow
53.6853.4336.750.4683.750

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
12.1518.842.43.52-16.16-70.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-41.53-34.59-34.353.06-99.91-70.69
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.39-0.34-0.450.05-2.08-1.85
Levered Free Cash Flow
-19.88-34.63-33.883.06-99.91-70.7
Unlevered Free Cash Flow
-20.12-34.85-34.461.96-100.11-70.85